Virginia Cancer Specialists Continues to Increase Access to Care in New, Expanded Fair Oaks, VA, Location, Now Open
Now in its 52nd year, Virginia Cancer Specialists continues to increase service and access to quality cancer care throughout Northern Virginia. The new 7,162 square foot Fair Oaks facility, which opened its doors on Monday, is Virginia Cancer Specialists’ third expansion in the last 6 months, with additional expansions planned for 2024 to accommodate new […]
Lymphedema Awareness Month -Shedding Light on Breast Cancer-Related Arm Lymphedema: A Call for Awareness and Action
Lymphedema Awareness Month – Part 1 March is a time dedicated to raising awareness about lymphedema, a condition that affects millions worldwide. Among the various forms of lymphedema, breast cancer-related arm lymphedema (BCRAL) stands out as a significant concern, impacting up to 20% of breast cancer survivors. As we mark Lymphedema Awareness Month, it’s crucial […]
Get the Facts: 5 Tips for Lowering Your Risk of Colorectal Cancer
When it comes to protecting your health, routine cancer screenings and positive lifestyle choices are key factors in prevention. Over the last few decades, screening tests for colorectal cancer, such as colonoscopies and stool-based tests, have improved both detection and outcomes for patients. However, doctors and researchers are sounding the alarm at the steady […]
Advancements in Colorectal Cancer Treatment: Insights from Samuel Lee, MD at Virginia Cancer Specialists
The treatment paradigm for colorectal cancer is continuously evolving towards more personalized treatment plans. With more research conducted over the past decade, we are transitioning away from a one-size-fits-all approach to more individualized treatments for all stages of colorectal cancer. Early and Locally Advanced Colon Cancer: Upfront surgery remains the mainstay of treatment. Treatment after […]
Revolutionizing Breast Cancer Care: Insights and Recommendations from a Pivotal Germline Mutation Testing Study
Dr. Patricia Rodriguez of Virginia Cancer Specialists, is a co-author of the joint guideline paper issued by the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SSO) that aims to provide evidence-based recommendations for healthcare professionals dealing with precision care for breast cancer patients. The main goal of this paper was […]
Abemaciclib in the Treatment of Early-Stage Hormone Receptor-Positive Breast Cancer – Anmol Singh, MD
Endocrine therapy remains a mainstay in the treatment of early-stage hormone receptor-positive breast cancer. However, oncologists continue to work on improving the risk of recurrence in patients whose tumors exhibit high-risk features, such as a larger size or lymph node involvement. The MonarchE trial, a randomized phase 3 trial in adults, examined how the addition […]
Brentuximab Vedotin: A Promising Frontline Therapy for Older Hodgkin Lymphoma Patients
A recent study published by Dr. Dipti Patel-Donnelly, of Virginia Cancer Specialists and colleagues has shed light on a groundbreaking approach in the treatment of advanced-stage classical Hodgkin lymphoma (cHL) in older patients. This noncomparative phase 2 study, detailed in the research article here, explores the efficacy of brentuximab vedotin (BV) in combination with dacarbazine […]
Enhancing Lung Cancer Treatment: The Promise of Perioperative Immunotherapy – Samantha DiBenedetto, MD
Introduction: Lung cancer remains one of the most challenging and life-threatening diseases; however, several exciting treatment advances show promising benefits. A recent study in which Virginia Cancer Specialists participated under the research leadership of Dr. Alex Spira, the AEGEAN trial, was published in the New England Journal of Medicine (NEJM) earlier this month and has shed light […]
November is Lung Cancer Awareness Month – Advancements in Lung Cancer Treatment
November is Lung Cancer Awareness Month. In recent years, lung cancer treatment has taken incredible steps forward, thanks to breakthrough research and early detection. Here are some of the latest advancements in treating lung cancer. Your browser does not support the video tag.
The Potential of Multicancer Early Detection Blood Tests: The PATHFINDER Study
Detecting cancer at an early, treatable stage remains challenging, but new technologies are offering hope. The PATHFINDER study <Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study>, conducted by a team of experts including Deb Schrag MD, Tomasz M. Beer MD, Charles H. McDonnell III MD and Robert Reid MD (of Virginia Cancer […]